Emergency Department-Initiated Medications for Alcohol Use Disorder

This study is looking at whether starting medications for Alcohol Use Disorder (AUD) in the Emergency Department (ED) can help more people get into treatment. You might receive Naltrexone as a pill or an injection, or Gabapentin as a pill. All participants will also receive a "Brief Negotiation Interview," which is a conversation to help you think about your alcohol use. The study wants to see if these interventions help people participate in AUD treatment 30 days after their ED visit. To join, you need to be between 18 and 80 years old, have moderate to severe AUD, and be willing to follow study procedures. The current recruitment status is unclear.

Study design
This is an interventional study with a planned enrollment of 240 participants. It is a randomized clinical trial, meaning participants will be assigned by chance to different treatment groups.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your participation in AUD treatment will be checked 30 days after you enroll in the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05827159

Emergency Department-Initiated Medications for Alcohol Use Disorder

Recruiting
PHASE3Ages 18–80InterventionalTreatment
Yale University
~240 participants
Updated 2026-07-21 on ClinicalTrials.gov
What's tested:Naltrexone PillNaltrexone InjectionBrief Negotiation InterviewGabapentin Pill

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Participation in AUD Treatment on Day 30 post-randomization
Measured over 30 days post enrollment
Alcohol Use Disorder
1 sites across 1 states
Connecticut1
  • Kathryn Hawk, MD, MHS · PRINCIPAL_INVESTIGATOR · Yale University

Opens a ready-to-send draft in your own email app — review before sending.

  • Participation in AUD Treatment on Day 30 post-randomization30 days post enrollment

    The proportions of participants participating in AUD treatment on day 30 post enrollment in SBIRT and SBIRT+EDMAUD groups.